Germline and somatic mutations in prostate cancer: focus on defective DNA repair, PARP inhibitors and immunotherapy-Reference-Cited by-同舟云学术

Germline and somatic mutations in prostate cancer: focus on defective DNA repair, PARP inhibitors and immunotherapy

Published:2020-02 Issue:5 Volume:16 Page:75-80
ISSN:1479-6694
Container-title:Future Oncology
language:en
Short-container-title:Future Oncology

Author:

Cimadamore Alessia¹^ORCID,Lopez-Beltran Antonio²,Massari Francesco³,Santoni Matteo⁴,Mazzucchelli Roberta¹,Scarpelli Marina¹,Galosi Andrea B⁵,Cheng Liang⁶^ORCID,Montironi Rodolfo¹

Affiliation:

1. Department of Pathological Anatomy, Polytechnic University of the Marche Region, School of Medicine, United Hospitals, Ancona, Italy

2. Department of Pathology & Surgery, Faculty of Medicine, Cordoba, Spain

3. Department of Oncology, S. Orsola-Malpighi Hospital, Bologna, Italy

4. Department of Oncology, Macerata Hospital, Macerata, Italy

5. Department of Urology, Polytechnic University of the Marche Region, United Hospitals, Ancona, Italy

6. Department of Pathology & Laboratory Medicine, Indiana University School of Medicine, Indianapolis, IN 46202, USA

Publisher

Future Medicine Ltd

Subject

Cancer Research,Oncology,General Medicine

Link

https://www.futuremedicine.com/doi/pdf/10.2217/fon-2019-0745

Reference42 articles.

1. Germline and Somatic Mutations in Prostate Cancer for the Clinician

2. Male BRCA mutation carriers: clinical characteristics and cancer spectrum

3. A Pilot Study of Clinical Targeted Next Generation Sequencing for Prostate Cancer: Consequences for Treatment and Genetic Counseling

4. Tumor clone dynamics in lethal prostate cancer

5. Distinct functions of BRCA1 and BRCA2 in double-strand break repair

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Homologous Recombination Repair Gene Mutations in Prostate Cancer: Prevalence and Clinical Value;Advances in Therapy;2024-05-20

2. Comprehensive Review on Recent Strategies for Management of Prostate Cancer: Therapeutic Targets and SAR;Mini-Reviews in Medicinal Chemistry;2024-04

3. Predictive and prognostic biomarkers in urological tumours;Pathology;2023-12

4. Racial disparity in the genomics of precision oncology of prostate cancer;Cancer Reports;2023-08-10

5. Germline Variants in DNA Damage Repair Genes and HOXB13 Among Black Patients With Early-Onset Prostate Cancer;JCO Precision Oncology;2022-11